{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T22:52:54Z","timestamp":1762642374325,"version":"build-2065373602"},"reference-count":20,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,6]],"date-time":"2021-11-06T00:00:00Z","timestamp":1636156800000},"content-version":"am","delay-in-days":370,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["M\u00e9decine et Maladies Infectieuses"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.medmal.2020.07.005","type":"journal-article","created":{"date-parts":[[2020,8,7]],"date-time":"2020-08-07T02:54:03Z","timestamp":1596768843000},"page":"742-745","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Ibrutinib, a Bruton's tyrosine kinase inhibitor, a new risk factor for cryptococcosis"],"prefix":"10.1016","volume":"50","author":[{"given":"J.","family":"Brochard","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Morio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Mahe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Le Pape","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Guimard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Mahe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Leterrier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Morrier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Raffi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Boutoille","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.medmal.2020.07.005_bib0105","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.3201\/eid2007.140087","article-title":"Population-based analysis of invasive fungal infections, France, 2001\u20132010","volume":"20","author":"Bitar","year":"2014","journal-title":"Emerg Infect Dis"},{"issue":"8","key":"10.1016\/j.medmal.2020.07.005_bib0110","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.3109\/10428194.2013.853299","article-title":"Invasive fungal infections in lymphoproliferative disorders: a monocentric retrospective experience","volume":"55","author":"Nosari","year":"2014","journal-title":"Leuk Lymphoma"},{"issue":"4","key":"10.1016\/j.medmal.2020.07.005_bib0115","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1002\/hon.2343","article-title":"Epidemiology and risk factors of invasive fungal infections in a large cohort of patients with chronic lymphocytic leukemia","volume":"35","author":"Visentin","year":"2017","journal-title":"Hematol Oncol"},{"key":"10.1016\/j.medmal.2020.07.005_bib0120","doi-asserted-by":"crossref","unstructured":"Tillman BF, Pauff JM, Satyanarayana G, Talbott M, Warner JL. Systematic review of infectious events with the Bruton tyrosine kinase inhibitor ibrutinib in the treatment of hematologic malignancies. Eur J Haematol 100(4):325-34.","DOI":"10.1111\/ejh.13020"},{"key":"10.1016\/j.medmal.2020.07.005_bib0125","doi-asserted-by":"crossref","unstructured":"Chamilos G, Lionakis MS, Kontoyiannis DP. Call for action: invasive fungal infections associated with ibrutinib and other small molecule kinase inhibitors targeting immune signaling pathways. Clin Infect Dis Jan 6;66(1):140-8.","DOI":"10.1093\/cid\/cix687"},{"issue":"4","key":"10.1016\/j.medmal.2020.07.005_bib0130","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00265-13","article-title":"X-linked immunodeficient mice exhibit enhanced susceptibility to Cryptococcus neoformans infection","volume":"4","author":"Szymczak","year":"2013","journal-title":"mBio"},{"issue":"6","key":"10.1016\/j.medmal.2020.07.005_bib0135","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a019638","article-title":"Mendelian genetics of human susceptibility to fungal infection","volume":"4","author":"Lionakis","year":"2014","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"12","key":"10.1016\/j.medmal.2020.07.005_bib0140","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005293","article-title":"CARD9-dependent neutrophil recruitment protects against fungal invasion of the central nervous system","volume":"11","author":"Drummond","year":"2015","journal-title":"PLoS Pathog"},{"issue":"1","key":"10.1016\/j.medmal.2020.07.005_bib0145","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1128\/IAI.74.1.144-151.2006","article-title":"Binding and internalization of glucuronoxylomannan, the major capsular polysaccharide of Cryptococcus neoformans, by murine peritoneal macrophages","volume":"74","author":"Chang","year":"2006","journal-title":"Infect Immun"},{"issue":"5","key":"10.1016\/j.medmal.2020.07.005_bib0150","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1093\/cid\/ciy175","article-title":"Serious infections in patients receiving ibrutinib for treatment of lymphoid cancer","volume":"67","author":"Varughese","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.medmal.2020.07.005_bib0155","first-page":"1082","article-title":"Primary cutaneous cryptococcosis in a patient with chronic lymphocytic leukemia: a case report","volume":"3","author":"Ajam","year":"2016","journal-title":"Ann Hematol Oncol"},{"key":"10.1016\/j.medmal.2020.07.005_bib0160","article-title":"Disseminated cryptococcal disease in a patient with chronic lymphocytic leukemia on ibrutinib","author":"Okamoto","year":"2016","journal-title":"Case Rep Infect Dis"},{"key":"10.1016\/j.medmal.2020.07.005_bib0165","first-page":"261","article-title":"Disseminated cryptococcosis with brain involvement in patients with chronic lymphoid malignancies on ibrutinib","volume":"26","author":"Messina","year":"2016","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.medmal.2020.07.005_bib0170","first-page":"1","article-title":"Fungal infections in patients treated with ibrutinib: two unusual cases of invasive aspergillosis and cryptococcal meningoencephalitis","volume":"30","author":"Baron","year":"2017","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.medmal.2020.07.005_bib0175","series-title":"Infections in the immunosuppressed patient: an illustrated case-based approach","first-page":"58","article-title":"A budding headache in a patient with hematological malignancy","author":"Chandrasekar","year":"2015"},{"issue":"9","key":"10.1016\/j.medmal.2020.07.005_bib0180","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1164\/rccm.201703-0601IM","article-title":"Pulmonary cryptococcus presenting as a solitary pulmonary nodule","volume":"196","author":"Sudhakaran","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.medmal.2020.07.005_bib0185","article-title":"Cryptococcal infections in two patients receiving ibrutinib therapy for chronic lymphocytic leukemia","volume":"1","author":"Stankowicz","year":"2018","journal-title":"J Oncol Pharm Pract"},{"key":"10.1016\/j.medmal.2020.07.005_bib0190","first-page":"12","article-title":"Cryptococcal meningoencephalitis in patients with mantle cell lymphoma on ibrutinib","author":"Sun","year":"2018","journal-title":"ecancermedicalscience"},{"key":"10.1016\/j.medmal.2020.07.005_bib0195","first-page":"2018","article-title":"Cryptococcus neoformans empyema in a patient receiving ibrutinib for diffuse large B-cell lymphoma and a review of the literature","volume":"18","author":"Swan","year":"2018","journal-title":"BMJ Case Rep"},{"issue":"2","key":"10.1016\/j.medmal.2020.07.005_bib0200","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1080\/15384047.2018.1508622","article-title":"Is ibrutinib associated with disseminated cryptococcosis with CNS involvement?","volume":"20","author":"Abid","year":"2019","journal-title":"Cancer Biol Ther"}],"container-title":["M\u00e9decine et Maladies Infectieuses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0399077X20306739?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0399077X20306739?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T01:20:55Z","timestamp":1759972855000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0399077X20306739"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":20,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["S0399077X20306739"],"URL":"https:\/\/doi.org\/10.1016\/j.medmal.2020.07.005","relation":{},"ISSN":["0399-077X"],"issn-type":[{"type":"print","value":"0399-077X"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ibrutinib, a Bruton's tyrosine kinase inhibitor, a new risk factor for cryptococcosis","name":"articletitle","label":"Article Title"},{"value":"M\u00e9decine et Maladies Infectieuses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medmal.2020.07.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}